1. Mixed‐phenotype acute leukemia with a predominant B/T and a small subset of myeloid lineage expression. Issue 2 (16th October 2020) Authors: Pourabdollah, Maryam; Eladl, Entsar; Liu, Aijun; Chang, Hong Journal: EJHaem Issue: Volume 1:Issue 2(2020) Page Start: 402 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Molecular characterization of AML‐MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC‐defining criteria, TP53 allelic state, or TP53 variant allele frequency. (16th November 2022) Authors: Zhao, Davidson; Eladl, Entsar; Zarif, Mojgan; Capo‐Chichi, José‐Mario; Schuh, Andre; Atenafu, Eshetu; Minden, Mark; Chang, Hong Journal: Cancer medicine Issue: Volume 12:Number 6(2023) Page Start: 6511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Molecular genetic characterization of Philadelphia chromosome-positive acute myeloid leukemia. (January 2023) Authors: Zhou, Qianghua; Zhao, Davidson; Eladl, Entsar; Capo-Chichi, Jose-Mario; Kim, Dennis Dong Hwan; Chang, Hong Journal: Leukemia research Issue: Volume 124(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. NPM1-mutated AML-MRC diagnosed on the basis of history of MDS or MDS/MPN frequently harbours secondary-type mutations and confers inferior outcome compared to AML with mutated NPM1. (July 2022) Authors: Zhao, Davidson; Zarif, Mojgan; Eladl, Entsar; Capo-Chichi, José-Mario; Smith, Adam C.; Atenafu, Eshetu G.; Tierens, Anne; Minden, Mark D.; Schuh, Andre; Chang, Hong Journal: Leukemia research Issue: Volume 118(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗